CN Patent

CN114907353A — 一种前药化合物及其制备方法和用途

Assigned to Minghui Pharmaceutical Hangzhou Ltd · Expires 2022-08-16 · 4y expired

What this patent protects

本发明提供了一种前药化合物及其制备方法和用途，具体地，本发明提供了一种如式(I)所示的化合物，及其制备方法和作为激酶抑制剂前药用于制备透皮给药制剂的用途。

USPTO Abstract

本发明提供了一种前药化合物及其制备方法和用途，具体地，本发明提供了一种如式(I)所示的化合物，及其制备方法和作为激酶抑制剂前药用于制备透皮给药制剂的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN114907353A
Jurisdiction
CN
Classification
—
Expires
2022-08-16
Drug substance claim
No
Drug product claim
No
Assignee
Minghui Pharmaceutical Hangzhou Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.